Interview Intersection: Expert Interviews From January 2026

Clinical Updates

Q&A: Adelle Walker on How Functional Wellness is Redefining Aesthetic Dermatology in 2026

Heap discusses promising phase 3 results for zasocitinib, an oral TYK2 inhibitor, showcasing its efficacy and safety in psoriasis therapy.

BioMendics CEO Karen McGuire, PhD, on Disease-Modifying Strategies for EB Simplex

Karen McGuire, PhD, discusses innovative TolaSure for treating epidermolysis bullosa simplex, focusing on disease modification rather than symptom management.

• MORE FROM McGUIRE: Outlining the Clinical Development Strategy of TolaSure for EB Simplex

Unique Perspectives

Derm Dispatch: Navigating the Ethics of AI-Assisted Dermatology

Renata Block, DMSc, MMS, PA-C, explores how AI could transform dermatology with insights from Dr. GPT on integration, equity, and the future of patient care.

Jennelle Daly, MPAS, PA-C, on Bridging the Gap in Winter UV Education and Patient Adherence

Jennelle Daly, MPAS, PA-C, reveals essential winter sunscreen insights, emphasizing UVA risks and patient education for effective photoprotection against melanoma.

Conference Insights

Del Rosso's What's New in the Medicine Chest 2026: Topicals

James Del Rosso, DO, discusses innovative topical therapies for dermatologic conditions.

Reflections and Looking Ahead

Practical Decisions Behind PDT for Actinic Keratosis

Michael O'Donoghue, MD, discusses tailoring PDT for AK, emphasizing patient preferences and flexible treatment strategies.

Derm Dispatch: The Growing Role of AI in Customized Dermatologic Care

Explore the transformative role of AI in dermatology with Nawar Shara, PhD, focusing on personalized skin care and patient safety.

Don’t miss a moment of Dermatology Times by signing up for our eNewsletters and subscribing to receive the free print issue and supplements each month.